Innovative and mundane

FDA approves novel non-uranium Mo-99 production process

The US Food and Drug Administration has approved NorthStar Medical Radioisotopes, LLC's process to produce molybdenum-99 from concentrated Mo-98 and related software upgrades for its RadioGenix System technetium-99m generator. This will significantly increase US production and capacity for non-uranium based Mo-99, the company says.

Related news

Forsmark unit 1 celebrates 40 years of operation
Bron: World Nuclear News11 december 2020
(Archieffoto van het reactorvat van Forsmark - Credit photo: ©Göran Hansson / Vattenfall)
Vogtle 3 receives first fuel delivery
Bron: World Nuclear News10 december 2020
(Photo credit: Georgia Power)

Related news

(Archieffoto van het reactorvat van Forsmark - Credit photo: ©Göran Hansson / Vattenfall)
(Photo credit: Georgia Power)
News overview